Yan Lau is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is currently studying for a PhD in Cancer Biology at King's College London. Her research focuses on antigen presentation in high-metastatic risk breast cancer. Previously, she studied Biomedical Science at Oxford Brookes University, followed by a Master's in Cancer at University College London.
A patient with B-cell acute lymphoblastic leukaemia has become the first adult to receive a pioneering cell therapy on the NHS...
Eleven people with aggressive T-cell leukaemia have now received a 'base editing' therapy, with seven remaining in remission up to three years after treatment...
CAR-T cell cancer treatments could be made safer and more durable by reprogramming T cells without altering their DNA, according to new research...
CRISPR/Cas9 has been used to identify genome editing targets that significantly enhance the efficiency of a targeted therapy for myeloma, a type of cancer...
A genome editing therapy can sharply reduce cholesterol levels in some patients, as shown in early results from a clinical trial...
A genomic study has identified five gene variants associated with earlier menopause and increased risk of cancer...
Researchers have discovered a potential mechanism underpinning why a person's genome might influence the subtype of breast cancer they develop...
Changing the expression of a specific protein can significantly improve the performance of immune-cell-based cancer therapies, according to two separate studies published in Nature...
Three separate clinical trials of engineered immune cells have reported results for treating glioblastoma, an aggressive and hard-to-treat brain cancer...
A genome-edited pig liver effectively filtered blood in a brain-dead man for three days, showcasing a potential temporary solution for acute liver failure...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
